Quest Diagnostics Inc. Stock Underperforms Monday When Compared To Competitors
Quest Diagnostics Inc. Stock Underperforms Monday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
本文由MarketWatch使用Automated Insights的技术自动生成。
Shares of Quest Diagnostics Inc. (DGX) slid 1.01% to $145.01 Monday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index rising 0.47% to 4,566.48 and the Dow Jones Industrial Average rising 0.18% to 35,741.15. Quest Diagnostics Inc. closed $15.55 below its 52-week high ($160.56), which the company achieved on September 9th.
周一，Quest Diagnostics Inc.股价下跌1.01%，至145.01美元，这是一个对股市全面有利的交易日，标准普尔500指数上涨0.47%，至4566.48点，道琼斯工业平均指数上涨0.18%，至35,741.15点。Quest Diagnostics Inc.的收盘价比该公司9月9日创下的52周高点(合160.56美元)低15.55美元。
The stock underperformed when compared to some of its competitors Monday, as Laboratory Corp. of America Holdings (LH) fell 0.38% to $281.07, Qiagen N.V. (QGEN) rose 0.48% to $54.25, and Sonic Healthcare Ltd. ADR rose 0.71% to $29.92. Trading volume (1.3 M) eclipsed its 50-day average volume of 1.3 M.
与一些竞争对手相比，该股周一表现不佳，美国实验室控股公司(Laboratory Corp.of America Holdings)下跌0.38%，至281.07美元，启根公司(Qiagen N.V.)上涨0.48%，至54.25美元，Sonic Healthcare Ltd.ADR上涨0.71%，至29.92美元。成交量(130万)超过了其50天平均成交量130万。
Data source: Dow Jones Market Data, FactSet. Data compiled October 25, 2021.
数据来源：道琼斯市场数据，FactSet。数据汇编于2021年10月25日。
-MarketWatch Automation
-MarketWatch自动化